Identification of Risk Factors for Cardiovascular Disease and Cancer in Korean Population: A Prospective Cohort Study
Launched by ULSAN UNIVERSITY HOSPITAL · May 21, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand the risk factors for heart disease and cancer in the Korean population. Since these two health issues are leading causes of death worldwide, researchers want to explore what factors might increase the chances of developing them. By studying the health behaviors and risk profiles of people, the trial aims to identify new factors that could help prevent these diseases.
To take part in this study, you need to be at least 19 years old and have had a general health screening at Ulsan University Hospital in Korea. If you're interested, you'll need to agree to participate by signing a consent form. Participants will share information about their health and lifestyle, which will help researchers gain valuable insights. This is an important opportunity to contribute to our understanding of how to reduce the risks of serious health conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men or women aged 19 years and older who underwent a general health screening at the health promotion center of Ulsan University Hospital (Ulsan, Korea)
- • Subjects have to agree to participate by signing a consent
- Exclusion Criteria:
- • Subjects who cannot or reject to sign the consent form.
About Ulsan University Hospital
Ulsan University Hospital is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital combines cutting-edge medical technology with a commitment to patient-centered care, fostering an environment where scientific inquiry and patient safety are paramount. With a multidisciplinary team of experienced healthcare professionals and researchers, Ulsan University Hospital aims to contribute to the development of new therapies and treatment protocols that enhance patient outcomes and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ulsan, , Korea, Republic Of
Ulsan, , Korea, Republic Of
Patients applied
Trial Officials
Sangwoo Park, MD
Principal Investigator
Ulsan University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials